减重代谢手术对肥胖型非酒精性脂肪肝治疗的意义

摘要/Abstract

中图分类号:

R589.2

花荣, 姚琪远. 减重代谢手术对肥胖型非酒精性脂肪肝治疗的意义[J]. 外科理论与实践, 2020, 25(05): 373-377.

HUA Rong, YAO Qiyuan. Impact of bariatric and metabolic surgery on nonalcoholic fatty liver disease[J]. Journal of Surgery Concepts & Practice, 2020, 25(05): 373-377.

参考文献42

[1]	NCD Risk Factor Collaboration(NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants[J]. Lancet, 2016, 387(10026):1377-1396.
[2]	Chalasani N, Younossi Z, Lavine J, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association[J]. Hepatology, 2012, 55(6):2005-2023. doi:10.1002/hep.25762pmid:22488764
[3]	Kleiner DE, Brunt EM, van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease[J]. Hepatology, 2005, 41(6):1313-1321. doi:10.1002/hep.20701pmid:15915461
[4]	Borges-Canha M, Neves JS, Mendonça F, et al. The impact of bariatric surgery on hepatic function and predictors of liver steatosis and fibrosis[J]. Obes Surg, 2020, 30(8):2935-2941. doi:10.1007/s11695-020-04622-0pmid:32306299
[5]	Younossi Z, Koenig A, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology, 2016, 64(1):73-84. doi:10.1002/hep.28431pmid:26707365
[6]	Mummadi RR, Kasturi KS, Chennareddygari S, et al. Effect of bariatric surgery on nonalcoholic fatty liver di-sease: a systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2008, 6(12):1396-1402.
[7]	Udelsman BV, Corey KE, Lindvall C, et al. Risk factors and prevalence of liver disease in review of 2557 routine liver biopsies performed during bariatric surgery[J]. Surg Obes Relat Dis, 2019, 15(6):843-849. doi:S1550-7289(19)30050-4pmid:31014948
[8]	Portillo Sanchez P, Bril F, Maximos M, et al. High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels[J]. J Clin Endocrinol Metab, 2015, 100(6):2231-2238. doi:10.1210/jc.2015-1966pmid:25885947
[9]	Agopian VG, Kaldas FM, Hong JC. Live transplantation for nonalcoholic steatohepatitis: the new epidemic[J]. Ann Surg, 2012, 256(4):624-633. doi:10.1097/SLA.0b013e31826b4b7epmid:22964732
[10]	Salman MA, Mikhail HMS, Nafea MA, et al. Impact of laparoscopic sleeve gastrectomy on fibrosis stage in patients with child-A NASH-related cirrhosis[J]. Surg Endosc, 2020. doi: 10.1007/s00464-020-07498-4. doi:10.1007/s00464-020-07498-4 URL
[11]	Younus H, Sharma A, Miquel R, et al. Bariatric surgery in cirrhotic patients: is it safe?[J]. Obes Surg, 2020, 30(4):1241-1248. doi:10.1007/s11695-019-04214-7pmid:31853866
[12]	Lazzati A, Iannelli A, Schneck AS, et al. Bariatric surgery and liver transplantation: a systematic review a new frontier for bariatric surgery[J]. Obes Surg, 2015, 25(1):134-142. doi:10.1007/s11695-014-1430-8pmid:25337867
[13]	Ayloo S, Gussa C, Ram S, et al. Minimally invasive sleeve gastrectomy as a surgical treatment for nonalcoholic fatty liver disease in liver transplant recipients[J]. Transplant Proc, 2020, 52(1):276-283
[14]	Gasteyger C, Larsen TM, Vercruysse F, et al. Effect of a dietary induced weight loss on liver enzymes in obese subjects[J]. Am J Clin Nutr, 2008, 87(5):1141-1147.
[15]	Baltasar A, Serra C, Perez N, et al. Clinical hepatic impairment after the duodenal switch[J]. Obes Surg, 2004, 14(1):77-83. pmid:14980038
[16]	Requarth JA, Burchard KW, Colacchio TA, et al. Long-term morbidity following jejunoileal bypass. The continuing potential need for surgical reversal[J]. Arch Surg, 1995, 130(3):318-325.
[17]	Eilenberg M, Langer FB, Beer A, et al. Significant liver-related morbidity after bariatric surgery and its reversal-a case series[J]. Obes Surg, 2018, 28(3):812-819.
[18]	Sugerman HJ, Kellum JM, DeMaria EJ. Conversion of proximal to distal gastric bypass for failed gastric bypass for superobesity[J]. J Gastrointest Surg, 1997, 1(6):517-524, discussion 524-526.
[19]	Baldwin D, Chennakesavalu M, Gangemi A. Systematic review and meta-analysis of Roux-en-Y gastric bypass against laparoscopic sleeve gastrectomy for amelioration of NAFLD using four criteria[J]. Surg Obes Relat Dis, 2019, 15(12):2123-2130. doi:S1550-7289(19)30997-9pmid:31711944
[20]	Fakhry TK, Mhaskar R, Schwitalla T, et al. Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis[J]. Surg Obes Relat Dis, 2019, 15(3):502-511.
[21]	Kwak M, Mehaffey JH, Hawkins RB, et al. Bariatric surgery is associated with reduction in non-alcoholic steatohepatitis and hepatocellular carcinoma: a propensity matched analysis[J]. Am J Surg, 2020, 219(3):504-507.
[22]	Wirth KM, Sheka AC, Kizy S, et al. Bariatric surgery is associated with decreased progression of nonalcoholic fatty liver disease to cirrhosis: a retrospective cohort analysis[J]. Ann Surg, 2020, 272(1):32-39.
[23]	Lambert JE, Ramos-Roman MA, Browning JD, et al. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease[J]. Gastroenterology, 2014, 146(3):726-735.
[24]	Tannapfel A, Denk H, Dienes HP, et al. Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease[J]. Virchows Arch, 2011, 458(5):511-523.
[25]	Jacome-Sosa MM, Parks EJ. Fatty acid sources and their fluxes as they contribute to plasma triglyceride concentrations and fatty liver in humans[J]. Curr Opin Lipidol, 2014, 25(3):213-220. doi:10.1097/MOL.0000000000000080pmid:24785962
[26]	Day CP, James OF. Steatohepatitis: a tale of two “hits”[J]. Gastroenterology, 1998, 114(4):842-845. pmid:9547102
[27]	Kozlitina J, Smagris E, Stender S, et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease[J]. Nat Genet, 2014, 46(4):352-356. doi:10.1038/ng.2901pmid:24531328
[28]	Sookoian S, Rosselli MS, Gemma C, et al. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter[J]. Hepatology, 2010, 52(6):1992-2000. doi:10.1002/hep.23927pmid:20890895
[29]	Luedde T, Kaplowitz N, Schwabe RF. Cell death and cell death responses in liver disease: mechanisms and clinical relevance[J]. Gastroenterology, 2014, 147(4):765-783.e4. doi:10.1053/j.gastro.2014.07.018pmid:25046161
[30]	Cusi K. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis[J]. Clin Liver Dis, 2009, 13(4):545-563.
[31]	Seki E, de Minicis S, Osterreicher CH, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis[J]. Nat Med, 2007, 13(11):1324-1332.
[32]	Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes-5-year outcomes[J]. N Engl J Med, 2017, 376(7):641-651.
[33]	Leonetti F, Capoccia D, Coccia F, et al. Obesity, type 2 diabetes mellitus, and other comorbidities: a prospective cohort study of laparoscopic sleeve gastrectomyvs. medical treatment[J]. Arch Surg, 2012, 147(8):694-700. pmid:22508671
[34]	Hua R, Wang GZ, Shen QW, et al. Sleeve gastrectomy ameliorated HFD-induced non-alcoholic fatty liver di-sease and upregulated the nicotinamide adenine dinucleotide +/Sirtuin-1 pathway in mice[J]. Asian J Surg,2020-07-22.doi: 10.1016/j.asjsur.2020.05.030. doi:10.1016/j.asjsur.2020.05.030 URL
[35]	Jørgensen NB, Jacobsen SH, Dirksen C, et al. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with type 2 diabetes and normal glucose tolerance[J]. Am J Physiol Endocrinol Metab, 2012, 303(1):E122-E131.
[36]	Svegliati-Baroni G, Saccomanno S, Rychlicki C, et al. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis[J]. Liver Int, 2011, 31(9):1285-1297. doi:10.1111/j.1478-3231.2011.02462.xpmid:21745271
[37]	Yousseif A, Emmanuel J, Karra E, et al. Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans[J]. Obes Surg, 2014, 24(2):241-252. doi:10.1007/s11695-013-1066-0pmid:23996294
[38]	Whang W, Liu Y, Kageyama S, et al. Vertical sleeve gastrectomy attenuates the progression of non-alcoholic steatohepatitis in mice on a high-fat high-cholesterol diet[J]. Obes Surg, 2019, 29(8):2420-2429.
[39]	Patti ME, Houten SM, Bianco AC, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism[J]. Obesity (Silver Spring), 2009, 17(9):1671-1677.
[40]	Nakatani H, Kasama K, Oshiro T, et al. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery[J]. Metabolism, 2009, 58(10):1400-1407.
[41]	Huang HH, Lee WJ, Chen SC, et al. Bile acid and fibroblast growth factor 19 regulation in obese diabetics, and non-alcoholic fatty liver disease after sleeve gastrectomy[J]. J Clin Med, 2019, 8(6):815-829.
[42]	Fei N, Bruneau A, Zhang X, et al. Endotoxin producers overgrowing in human gut microbiota as the causative agents for nonalcoholic fatty liver disease[J]. mBio, 2020, 11(1):e03263-19.

减重代谢手术对肥胖型非酒精性脂肪肝治疗的意义

Impact of bariatric and metabolic surgery on nonalcoholic fatty liver disease

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献42

相关文章15

编辑推荐

Metrics

本文评价

[1]	张瑞祥, 孙烁烁, 韦晓, 刘超.传统及新型调脂药物在非酒精性脂肪性肝病治疗中的价值[J]. 内科理论与实践, 2023, 18(03): 215-220.
[2]	张贵祥, 陈刚, 李正正, 陈亿, 杜潇, 程中.减重代谢手术病人代谢危险因素与骨代谢血清标志物关系的研究[J]. 外科理论与实践, 2020, 25(06): 493-497.
[3]	胡嵩浩, 董志勇, 王存川.减重代谢手术的规范化与术式创新[J]. 外科理论与实践, 2020, 25(05): 361-363.
[4]	闫文貌, 白日星.减重代谢术后体重反弹的原因和防治措施[J]. 外科理论与实践, 2020, 25(05): 386-390.
[5]	朱孝成, 侯栋升.新型减重代谢手术方式：袖状胃切除加双通路[J]. 外科理论与实践, 2020, 25(05): 391-396.
[6]	廉东波, 刘晨, 闫巍, 杜德晓, 宫轲, 张能维.减重代谢手术效果评价系统的应用[J]. 外科理论与实践, 2020, 25(05): 402-407.
[7]	刘瑞萍, 杨宁琍, 林士波, 管蔚, 梁辉.三种减重代谢手术后妊娠结局及妊娠期并发症[J]. 外科理论与实践, 2020, 25(05): 408-412.
[8]	刘彦旸, 花荣, 许博, 沈奇伟, 黄先觉, 姚琪远.新鲜冰冻尸体腹腔镜减重代谢手术的探索与实践[J]. 外科理论与实践, 2020, 25(05): 417-421.
[9]	董艳彬, 苏梅, 张希龙,.中重度阻塞性睡眠呼吸暂停综合征与非酒精性脂肪性肝病相关性研究[J]. 内科理论与实践, 2019, 14(01): 30-34.
[10]	白洁, 陶凯雄.达芬奇机器人在代谢手术领域的应用[J]. 外科理论与实践, 2018, 23(06): 491-494.
[11]	花荣, 姚琪远.病态肥胖伴胃食管反流病的减重术式选择[J]. 外科理论与实践, 2018, 23(06): 499-501.
[12]	花荣, 陈浩, 丁锐, 许博, 沈奇伟, 姚琪远,.袖状胃切除手术前后的胃食管反流病[J]. 外科理论与实践, 2017, 22(06): 493-498.
[13]	陶婷, 吴霖, 谢雨苏, 吴方,.老年男性非酒精性脂肪肝患者血清胎球蛋白A水平的变化[J]. 内科理论与实践, 2014, 9(05): 325-327.
[14]	林如海, 吕晓斐, 徐佰慧, 丁琳, 徐敏, 张迪, 毕宇芳, 王卫庆,.中老年人血清铁与非酒精性脂肪肝的相关性研究[J]. 内科理论与实践, 2014, 9(05): 320-324.
[15]	焦阳, 汪娥, 陆炎, 李小英,.非酒精性脂肪性肝病的发病机制[J]. 诊断学理论与实践, 2014, 13(02): 111-115.